Stock Scorecard
Stock Summary for Acutus Medical Inc (AFIB) - $0.17 as of 4/19/2024 12:51:50 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AFIB
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AFIB
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AFIB
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for AFIB
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for AFIB
Financial Details for AFIB
Company Overview |
|
---|---|
Ticker | AFIB |
Company Name | Acutus Medical Inc |
Country | USA |
Description | Acutus Medical, Inc., an arrhythmia management company, designs, manufactures and markets a range of tools for catheter ablation procedures to treat various arrhythmias in the United States and internationally. The company is headquartered in Carlsbad, California. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 3/31/2024 |
Next Earnings Date | 5/9/2024 |
Stock Price History |
|
Last Day Price | 0.17 |
Last Day Price Updated | 4/19/2024 12:51:50 PM EST |
Last Day Volume | 732,616 |
Average Daily Volume | 689,103 |
52-Week High | 1.09 |
52-Week Low | 0.16 |
Last Price to 52 Week Low | 6.25% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 48.25 |
Sector PE | 61.34 |
5-Year Average PE | -0.53 |
Free Cash Flow Ratio | 0.23 |
Industry Free Cash Flow Ratio | 61.76 |
Sector Free Cash Flow Ratio | 30.17 |
Current Ratio Most Recent Quarter | 2.44 |
Total Cash Per Share | 0.75 |
Book Value Per Share Most Recent Quarter | -0.03 |
Price to Book Ratio | 0.53 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 0.73 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.19 |
Share Statistics |
|
Total Shares Outstanding | 29,716,000 |
Market Capitalization | 5,051,720 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -106.14% |
Reported EPS 12 Trailing Months | -0.41 |
Reported EPS Past Year | -1.65 |
Reported EPS Prior Year | -2.69 |
Net Income Twelve Trailing Months | -81,663,000 |
Net Income Past Year | -81,663,000 |
Net Income Prior Year | -39,616,000 |
Quarterly Revenue Growth YOY | 43.70% |
5-Year Revenue Growth | -2.49% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 22,370,000 |
Total Cash Past Year | 22,370,000 |
Total Cash Prior Year | 70,400,000 |
Net Cash Position Most Recent Quarter | -12,148,000 |
Net Cash Position Past Year | -12,148,000 |
Long Term Debt Past Year | 34,518,000 |
Long Term Debt Prior Year | 34,434,000 |
Total Debt Most Recent Quarter | 34,518,000 |
Equity to Debt Ratio Past Year | -0.03 |
Equity to Debt Ratio Most Recent Quarter | -0.03 |
Total Stockholder Equity Past Year | -879,000 |
Total Stockholder Equity Prior Year | 75,019,000 |
Total Stockholder Equity Most Recent Quarter | -879,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.01 |
MACD Signal | -0.01 |
20-Day Bollinger Lower Band | 0.16 |
20-Day Bollinger Middle Band | 0.19 |
20-Day Bollinger Upper Band | 0.23 |
Beta | 0.20 |
RSI | 42.16 |
50-Day SMA | 0.48 |
200-Day SMA | 0.00 |
System |
|
Modified | 4/18/2024 4:50:13 PM EST |